Investor login
Our Firm
Overview
Our History
Our People
Our Business
Overview
How we invest in Africa
Impact & ESG
Overview
History
Our Impact Agenda
IESG organisations
Reporting
Our Portfolio
News
News & Press Releases
Insights
Film Library
Contact
Search
back
09 Mar 2022
DPI CDC announce KELIX bio agreement to acquire PHI $200m second funding round
https://www.dpi-llp.com/wp-content/uploads/2022/03/DPI-CDC-announce-KELIX-bio-agreement-to-acquire-PHI-200m-second-funding-round_vfinal.pdf
Related articles
Kazyon attracts $165 million investment from DPI-led consortium
DPI-led consortium to buy Solevo, a leading African distributor of specialty chemicals from Helios
Marcyrl attracts new investment from DPI and Amethis
See all news